Technical Analysis for STAA - STAAR Surgical Company

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures and sells implantable lenses for the eye. It offers intraocular lenses (IOL) that include silicone Toric IOL, which is used in cataract surgery to treat preexisting astigmatism; Preloaded Injector, a silicone or acrylic IOL preloaded into a single-use disposable injector; Aspheric IOLs that provide a clearer image than traditional spherical lenses; and nanoFLEX IOL, a single-piece collamer aspheric optic. The company also provides implantable collamer lenses (ICL) comprising VISIAN ICL to treat vision disorders, such as myopia, hyperopia, and astigmatism; Toric ICL, a variant of the ICL that corrects astigmatism and myopia in a single lens; and Hyperopic ICL, which treats far-sightedness. In addition, it sells surgical products and other related instruments, as well as manufactures AquaFlow device for the treatment of glaucoma. The company markets its products to health care providers, including surgical centers, hospitals, managed care providers, health maintenance organizations, group purchasing organizations, and government facilities primarily under the STAAR, Visian, Collamer, nanoFLEX, nanoPOINT, Epiphany, and AquaFlow names. It distributes its products through directly employed representatives, independent sales representatives, and local distributors in the United States and internationally. The company was founded in 1982 and is headquartered in Monrovia, California.